Title : Glycopyrronium/Formoterol: A Review in COPD.

Pub. Date : 2019 Sep

PMID : 31468315






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Glycopyrronium/formoterol (Bevespi Aerosphere ) is a fixed-dose combination of the long-acting muscarinic antagonist glycopyrronium bromide and the long-acting beta2-agonist formoterol fumarate delivered via a pressurized metered dose inhaler (pMDI) and formulated using co-suspension delivery technology. Formoterol Fumarate potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens
2 Glycopyrronium/formoterol (Bevespi Aerosphere ) is a fixed-dose combination of the long-acting muscarinic antagonist glycopyrronium bromide and the long-acting beta2-agonist formoterol fumarate delivered via a pressurized metered dose inhaler (pMDI) and formulated using co-suspension delivery technology. Formoterol Fumarate potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens